Recent studies further demonstrate that A20 expression is downregulated in skin and lung tissues of SSc patients, as well as in fibroblasts, correlating with increased expression of profibrotic mediators such as Col1a1 and fibronectin (9). This evidence concerns the gene FN1 and systemic sclerosis.